Kairos Discovery
Capital Cell
- Estimated return
- up to 20×
- platform's estimate
- Valuation
- €3,294,118
Raising €850k
From €1,000
See project
Projects open for investment
IRUBIS
Companisto
- Estimated return
- up to 438.84%
- platform's estimate
- Valuation
- €14,000,000
Raising €1.1m
From €250
See project
Airway Shield
Capital Cell
- Estimated return
- up to 8×
- platform's estimate
- Valuation
- €8,000,000
Raising €800k
From €1,000
See project
Time is Brain
Capital Cell
- Estimated return
- up to 13×
- platform's estimate
- Valuation
- €12,000,000
Raising €2.5m
From €1,000
See project
PLACED
Companisto
- Estimated return
- up to 401.58%
- platform's estimate
- Valuation
- €5,900,000
Raising €1.2m
From €250
See project
V21 GmbH
FunderNation
- Estimated return
- 3.03–5.49×
- platform's estimate
- Valuation
- €2,750,000
Raising €1m
From €100
See project
Points2BIM GmbH
Companisto
- Estimated return
- up to 304.06%
- platform's estimate
- Valuation
- €6,200,000
Raising €450k
From €250
See project
Biogener
CrowdFundMe
- Estimated return
- 5–7×
- platform's estimate
- Valuation
- €89,952,077
Raising €250k
From €576
See project
Capital at risk. Most startups fail; estimates are the platform's own claims. Shares are hard to sell before an exit.
This didn't load
Check your connection and try again. Your filters are kept.